Ovary removal may increase lung cancer risk
This press release is available in French. Montreal, July 21, 2009 – Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer. The startling link was made by epidemiologists from the Université de Montréal, the Research Centre of the Centre Hospitalier de l'Université de Montréal and the INRS—Institut Armand-Frappier.
"We found that women who experienced non-natural menopause are at almost twice the risk of developing lung cancer compared to women who experienced natural menopause," says Anita Koushik, a researcher at the Université de Montréal's Department of Social and Preventive Medicine and a scientist at the Research Centre of the Centre Hospitalier de l'Université de Montréal. "This increased risk of lung cancer was particularly observed among women who had non-natural menopause by having had both their ovaries surgically removed."
The scientists studied 422 women with lung cancer and 577 control subjects at 18 hospitals across Montreal, Quebec, Canada. They assessed socio-demographic characteristics, residential history, occupational exposures, medical and smoking history, and (among women) menstruation and pregnancy histories.
"A major strength of this study was the detailed smoking information which we obtained from all study participants; this is important because of the role of smoking in lung cancer and because smokers generally have lower estrogen levels than non-smokers," says Dr. Koushik. "Although smoking is the dominant cause of lung cancer, we know other factors can play an important role in enhancing the impact of tobacco carcinogens; this research suggests that in women hormonal factors may play such a role."
Women were considered menopausal if their menstrual periods had stopped naturally, surgically (by hysterectomy with bilateral surgical ovary removal) or because of radiation or chemotherapy. Women who had at least one remaining ovary and who still had their menstrual periods at the time of diagnosis/interview were classified as premenopausal. Among participants with natural menopause, the median age for attaining menopause was 50 years old; among those with non-natural menopause, it was at 43 years.
"Non-natural menopause, particularly surgical menopause, may represent an increased risk with younger age at menopause given that surgery is usually done before natural menopause occurs. It's possible that vulnerability to lung cancer is caused by early and sudden decrease in estrogen levels or potentially long-term use of hormone replacement therapy and further research is needed to explore these hypotheses," says Jack Siemiatycki a professor at the Université de Montréal's Department of Social and Preventive Medicine and a scientist at the Research Centre of the Centre Hospitalier de l'Université de Montréal.
Source: University of Montreal
Related
- Heavy drinkers face significantly increased cancer riskMon, 3 Aug 2009, 11:51:56 EDT
- Drugs to treat anemia in cancer patients linked to thromboembolismTue, 10 Nov 2009, 17:46:10 EST
- Creating lung cancer risk models for specific populations refines predictionFri, 5 Sep 2008, 12:22:41 EDT
- Study finds that practice makes perfect in lung cancer surgeryThu, 23 Oct 2008, 14:23:57 EDT
- Genetic mutation associated with increased risk of lung cancerMon, 26 May 2008, 17:07:27 EDT
Articles on the same topic
- JNCI news brief: Thalidomide does not improve survival in small cell lung cancerThu, 16 Jul 2009, 16:38:48 EDT
Other sources
- Radon in homes raises lung cancer risk, says UN reportfrom CBC: HealthWed, 22 Jul 2009, 14:07:04 EDT
- Ovary Removal May Increase Lung Cancer Riskfrom Science DailyTue, 21 Jul 2009, 11:35:14 EDT
- Thalidomide Does Not Improve Survival In Small Cell Lung Cancer, Study Findsfrom Science DailyMon, 20 Jul 2009, 3:14:43 EDT
- Thalidomide lung cancer 'failure'from BBC News: Science & NatureFri, 17 Jul 2009, 19:14:11 EDT
- Thalidomide does not improve survival in small cell lung cancerfrom Science CentricThu, 16 Jul 2009, 23:42:09 EDT
- Thalidomide does not improve survival in small cell lung cancerfrom PhysorgThu, 16 Jul 2009, 16:35:18 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- First black holes may have incubated in giant, starlike cocoons, says CU-Boulder study
- Study shows flavanol antioxidant content of US chocolate and cocoa-containing products
- Protein from pregnancy hormone may prevent breast cancer
- Global study of salmon shows: 'Sustainable' food isn't so sustainable
- Biology, training and profit sharing make best traders
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Generating electricity from air flow
- Therapy 32 times more cost effective at increasing happiness than money
- Beyond genomics, biologists and engineers decode the next frontier
- It's a gas: New discovery may lead to heartier, high-yielding plants
- Therapy 32 times more cost effective at increasing happiness than money
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Full recovery now possible for an 'untreatable' mental illness
- Surface bacteria maintain skin's healthy balance
- Is global warming unstoppable?
- New evidence that dark chocolate helps ease emotional stress
- African desert rift confirmed as new ocean in the making
- Scientists discover influenza's Achilles heel: Antioxidants
- Nanoparticles used in common household items caused genetic damage in mice
- New study links vitamin D deficiency to cardiovascular disease and death